Correlation
The correlation between CPIX and ABBV is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
CPIX vs. ABBV
Compare and contrast key facts about Cumberland Pharmaceuticals Inc. (CPIX) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CPIX or ABBV.
Performance
CPIX vs. ABBV - Performance Comparison
Loading data...
Key characteristics
CPIX:
1.58
ABBV:
0.83
CPIX:
3.79
ABBV:
1.21
CPIX:
1.46
ABBV:
1.19
CPIX:
2.45
ABBV:
1.17
CPIX:
11.36
ABBV:
2.66
CPIX:
20.21%
ABBV:
9.07%
CPIX:
154.86%
ABBV:
28.28%
CPIX:
-93.78%
ABBV:
-45.09%
CPIX:
-70.90%
ABBV:
-13.31%
Fundamentals
CPIX:
$75.25M
ABBV:
$328.74B
CPIX:
-$0.24
ABBV:
$2.34
CPIX:
0.00
ABBV:
0.40
CPIX:
1.83
ABBV:
5.73
CPIX:
2.63
ABBV:
230.90
CPIX:
$41.08M
ABBV:
$57.37B
CPIX:
$32.01M
ABBV:
$44.44B
CPIX:
$1.81M
ABBV:
$16.36B
Returns By Period
In the year-to-date period, CPIX achieves a 109.28% return, which is significantly higher than ABBV's 6.70% return. Over the past 10 years, CPIX has underperformed ABBV with an annualized return of -3.34%, while ABBV has yielded a comparatively higher 15.54% annualized return.
CPIX
109.28%
3.12%
254.29%
235.14%
33.39%
8.43%
-3.34%
ABBV
6.70%
-3.74%
3.65%
19.62%
12.26%
19.77%
15.54%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CPIX vs. ABBV — Risk-Adjusted Performance Rank
CPIX
ABBV
CPIX vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Cumberland Pharmaceuticals Inc. (CPIX) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
CPIX vs. ABBV - Dividend Comparison
CPIX has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.43%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPIX Cumberland Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ABBV AbbVie Inc. | 3.43% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
CPIX vs. ABBV - Drawdown Comparison
The maximum CPIX drawdown since its inception was -93.78%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for CPIX and ABBV.
Loading data...
Volatility
CPIX vs. ABBV - Volatility Comparison
Cumberland Pharmaceuticals Inc. (CPIX) has a higher volatility of 34.27% compared to AbbVie Inc. (ABBV) at 9.85%. This indicates that CPIX's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
CPIX vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Cumberland Pharmaceuticals Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CPIX vs. ABBV - Profitability Comparison
CPIX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Cumberland Pharmaceuticals Inc. reported a gross profit of 10.29M and revenue of 11.71M. Therefore, the gross margin over that period was 87.8%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
CPIX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Cumberland Pharmaceuticals Inc. reported an operating income of 1.29M and revenue of 11.71M, resulting in an operating margin of 11.0%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
CPIX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Cumberland Pharmaceuticals Inc. reported a net income of 1.26M and revenue of 11.71M, resulting in a net margin of 10.7%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.